Duranton J, Adam C, Bieth J G
Laboratoire d'Enzymologie, INSERM U 392, Université Louis Pasteur de Strasbourg, France.
Biochemistry. 1998 Aug 11;37(32):11239-45. doi: 10.1021/bi980223q.
Uncontrolled proteolysis due to cathepsin G (cat G) may cause severe pathological disorders. Cat G is inhibited by alpha 1-antichymotrypsin (ACT) and alpha 1-proteinase inhibitor (alpha 1PI), two members of the serpin superfamily of proteins. To see whether these two inhibitors play a physiological proteolysis-preventing function, we have made a detailed kinetic investigation of their reaction with cat G. The kinetics of inhibition of cat G in the presence of inhibitor and substrate evidenced a two-step inhibition mechanism: E + I EI EI. The cat G/ACT interaction is described by Ki = 6.2 x 10(-)8 M and k2 = 2.8 x 10(-)2 s-1, while the cat G/alpha 1PI association is governed by Ki = 8.1 x 10(-)7 M and k2 = 5.5 x 10(-)2 s-1. The reliability of these kinetic constants was checked using a number of experiments which all gave consistent results: (i) both EI complexes were found to be enzymatically inactive, (ii) the Ki values were determined directly using initial velocity experiments of cat G-catalyzed hydrolysis of substrate in the presence of inhibitor, (iii) the second-order rate constants k2/Ki were measured using second-order inhibition experiments in the absence of substrate, and (iv) the ratio of the two second-order rate constants was determined by measuring the partition of cat G between the two fluorescently labeled serpins. Since the plasma concentrations of ACT and alpha 1PI are much higher than their Ki values, cat G released from neutrophils will be fully taken up as rapidly forming EI complexes, that is, 70% with ACT and 30% with alpha 1PI. Both ACT and alpha 1PI are thus physiological cat G inhibitors whose inhibitory potential does not depend on the formation of the stable inhibitory species EI characteristic of serpins. Such an in vivo inhibition mechanism might take place with other serpin/proteinase systems.
组织蛋白酶G(cat G)导致的不受控制的蛋白水解可能会引发严重的病理紊乱。Cat G受到α1 - 抗糜蛋白酶(ACT)和α1 - 蛋白酶抑制剂(α1PI)的抑制,这两种蛋白是丝氨酸蛋白酶抑制剂(serpin)超家族的成员。为了探究这两种抑制剂是否发挥生理上防止蛋白水解的功能,我们对它们与cat G的反应进行了详细的动力学研究。在存在抑制剂和底物的情况下对cat G抑制的动力学证明了一种两步抑制机制:E + I→EI→EI。cat G与ACT相互作用的描述为Ki = 6.2×10⁻⁸ M,k2 = 2.8×10⁻² s⁻¹,而cat G与α1PI的结合由Ki = 8.1×10⁻⁷ M和k2 = 5.5×10⁻² s⁻¹决定。通过一系列实验检验了这些动力学常数的可靠性,所有实验结果均一致:(i)发现两种EI复合物均无酶活性;(ii)Ki值通过在存在抑制剂的情况下cat G催化底物水解的初始速度实验直接测定;(iii)二级速率常数k2/Ki通过在不存在底物的情况下的二级抑制实验测量;(iv)通过测量cat G在两种荧光标记的丝氨酸蛋白酶抑制剂之间的分配来确定两个二级速率常数的比值。由于ACT和α1PI的血浆浓度远高于它们的Ki值,从中性粒细胞释放的cat G将迅速形成EI复合物而被完全摄取,即70%与ACT结合,30%与α1PI结合。因此,ACT和α1PI都是生理性的cat G抑制剂,其抑制潜力不依赖于丝氨酸蛋白酶抑制剂特有的稳定抑制物种EI的形成。这种体内抑制机制可能也适用于其他丝氨酸蛋白酶抑制剂/蛋白酶系统。